MY ACCOUNT | NEWSLETTER |

Veterinarian COVID-19 vaccine uptake was widespread, but safety and efficacy concerns held some back


Objective

Assess COVID-19 vaccine uptake among veterinarians and describe unvaccinated veterinarians’ perceptions of COVID-19 disease and vaccines.

Sample

2,721 (14%) of 19,654 randomly sampled AVMA members.

Procedures

A survey of AVMA members was conducted between June 8 and June 18, 2021. Information was collected on COVID-19 experience, vaccination intention, and perceptions of COVID-19 disease and vaccines.

Results

A total of 2,721 AVMA members completed the survey. Most respondents reported receiving a COVID-19 vaccine (89% [2,428/2,721]). Most unvaccinated respondents disagreed with concerns about contracting (67% [196/292]) or being harmed by (65% [187/287]) COVID-19 but agreed with concerns about short- (79% [228/290]) and long-term (89% [258/289]) side effects of COVID-19 vaccines. Over 91% (268/292) did not agree that COVID-19 vaccine benefits outweigh the risk. Although 83% (244/293) of unvaccinated respondents reported being unlikely to get a COVID-19 vaccine, 47% (137/291) agreed they would be more likely if they knew people vaccinated without serious side effects. Perceptions of COVID-19 disease severity and susceptibility, beliefs about COVID-19 vaccine benefits, and barriers and facilitators to COVID-19 vaccination varied with vaccination intention.

Clinical relevance

As community leaders, veterinarians’ beliefs and behaviors surrounding public health concerns such as COVID-19 may transfer to clients and veterinary staff. Results of the AVMA survey suggested that COVID-19 vaccination was widespread among veterinarians in June 2021. Despite COVID-19 safety protocols, veterinary practices still experienced veterinary team member shortages because of COVID-19 exposures and illnesses, which further impacted the availability and efficiency of services veterinary practices could deliver.

Understanding unvaccinated respondents’ health beliefs about COVID-19 and COVID-19 vaccines may facilitate veterinarian vaccination participation. Veterinarians who abstained from COVID-19 vaccination cited concerns about the safety, efficacy, and necessity of COVID-19 vaccines. Our results suggested that demonstrating vaccine safety and a favorable risk-to-benefit ratio of vaccination may help reduce vaccine hesitancy and increase uptake of COVID-19 vaccines among veterinarians.

Lauren E. Benishek, Suzanne E. Tomasi and Laura Pike. "Veterinarian COVID-19 vaccine uptake was widespread, but safety and efficacy concerns held some back: descriptive results from a survey of AVMA members’ perceptions of COVID-19." Journal of the American Veterinary Medical Association. Volume 261: Issue 5. Online Publication Date: 09 Jan 2023. DOI: https://doi.org/10.2460/javma.22.07.0328



Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top